Efficacy of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

By Lind Pehr   Naucler Gisela   Holm Agneta   Gubanski Michael   Svensson Christer  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 230-233

Informa Healthcare

Access to resources Recommend Favorite

Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma

By  

Medical Oncology, Vol. 24, Iss. 2, 2007-06 ,pp. : 227-230

Humana Press, Inc

Access to resources Recommend Favorite

RF ablation with adjuvant therapy: Comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model

By Solazzo Stephanie   Mertyna Pawel   Peddi Himija   Ahmed Muneeb   Horkan Clare   Nahum Goldberg S.  

International Journal of Hyperthermia, Vol. 24, Iss. 7, 2008-01 ,pp. : 560-567

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model

By              

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 678-684

Spandidos Publications

Access to resources Recommend Favorite

The Costs and Efficacy of Liposomal Doxorubicin in Platinum-Refractory Ovarian Cancer in Heavily Pretreated Patients

By Hensley M.L.   Hoppe B.   Leon L.   Sabbatini P.   Aghajanian C.   Chi D.   Spriggs D.R.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 464-469

Elsevier

Access to resources Recommend Favorite